Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Connect Biopharma Holdings Ltd issued 6,130,000 shares of common stock to institutional accredited investors for $3.25 per Share.
- Security
- common stock
- Shares
- 6,130,000 shares
- Purchaser
- institutional accredited investors
- Consideration
- $3.25 per Share
Exact text from the filing
On March 29, 2026, Connect Biopharma Holdings Limited (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with the purchasers named therein (the "Purchasers"), for the private placement (the "Private Placement") of 6,130,000 shares (the "Shares") of the Company's ordinary shares, par value $0.000174 per share (the "Ordinary Shares"), at a price of $3.25 per Share with respect to any Purchaser that is not owned or controlled by an individual who is an officer, director, employee or consultant of the Company.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
Connect Biopharma Holdings Ltd entered into Purchase Agreement with the purchasers named therein valued at approximately $20.2 million (effective 2026-03-29).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- the purchasers named therein
- Value
- approximately $20.2 million
- Effective
- 2026-03-29
Exact text from the filing
On March 29, 2026, Connect Biopharma Holdings Limited (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of 6,130,000 shares (the “Shares”) of the Company’s ordinary shares, par value $0.000174 per share (the “Ordinary Shares”), at a price of $3.25 per Share
View on SEC.gov